Safety Shot Inc (SHOT) Stock: A Look at the Analyst Recommendations

XPO

SHOT has 36-month beta value of 1.53. Analysts have mixed views on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”

The public float for SHOT is 64.77M, and currently, short sellers hold a 7.16% ratio of that float. The average trading volume of SHOT on June 11, 2025 was 1.95M shares.

SHOT) stock’s latest price update

The stock of Safety Shot Inc (NASDAQ: SHOT) has decreased by -6.05 when compared to last closing price of 0.27. Despite this, the company has experienced a -2.62% fall in its stock price over the last five trading sessions. globenewswire.com reported 2025-06-03 that Company to Expand Patented Wellness Approach into High-Growth Cognitive and Restorative Sleep Markets, Emphasizing Scientific Rigor and Unique Formulations SCOTTSDALE, AZ, June 03, 2025 (GLOBE NEWSWIRE) — Safety Shot, Inc. (Nasdaq: SHOT) (“Safety Shot” or the “Company”), a wellness and dietary supplement company known for Sure Shot™, its patented product that rapidly lowers blood alcohol content by supporting its metabolism, today announced the initiation of research and development (R&D) for innovative new product lines. These forthcoming offerings will target the rapidly expanding market for nootropics – supplements designed to support cognitive function – and the growing demand for effective sleep and relaxation aids.

SHOT’s Market Performance

Safety Shot Inc (SHOT) has seen a -2.62% fall in stock performance for the week, with a -49.04% decline in the past month and a -47.64% plunge in the past quarter. The volatility ratio for the week is 2.25%, and the volatility levels for the past 30 days are at 6.24% for SHOT. The simple moving average for the past 20 days is -23.54% for SHOT’s stock, with a -64.76% simple moving average for the past 200 days.

SHOT Trading at -37.96% from the 50-Day Moving Average

After a stumble in the market that brought SHOT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -85.69% of loss for the given period.

#####

#####

Insider Trading

Reports are indicating that there were more than several insider trading activities at SHOT starting from Melton Christopher, who sale 3,470 shares at the price of $0.85 back on Dec 11 ’24. After this action, Melton Christopher now owns 62,530 shares of Safety Shot Inc, valued at $2,967 using the latest closing price.

Safety Shot, Inc., the 10% Owner of Safety Shot Inc, sale 15,398 shares at $0.82 during a trade that took place back on Dec 10 ’24, which means that Safety Shot, Inc. is holding 2,857,511 shares at $12,626 based on the most recent closing price.

Stock Fundamentals for SHOT

Current profitability levels for the company are sitting at:

  • -36.01 for the present operating margin
  • -2.4 for the gross margin

The net margin for Safety Shot Inc stands at -42.11. The total capital return value is set at 20.52. Equity return is now at value -1514.12, with -425.07 for asset returns.

Based on Safety Shot Inc (SHOT), the company’s capital structure generated 1.63 points at debt to capital in total, while cash flow to debt ratio is standing at -3.39. The debt to equity ratio resting at -2.59. The interest coverage ratio of the stock is -240.18.

Currently, EBITDA for the company is -47.81 million with net debt to EBITDA at -0.11. When we switch over and look at the enterprise to sales, we see a ratio of 21.29. The receivables turnover for the company is 1.48for trailing twelve months and the total asset turnover is 0.16. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.44.

Conclusion

To put it simply, Safety Shot Inc (SHOT) has had a bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.

Most Popular

Related Posts

favicon-nh
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.